Anna Ringler
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
5-Arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones with selective inhibitory activity against some leukemia cell lines.
Journal: Archiv der Pharmazie
Published: September 10, 2020
MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation.
Journal: Nature genetics
Published: April 18, 2018
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease.
Journal: Cancer cell
Published: March 15, 2018
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.
Journal: Nature chemical biology
Published: November 15, 2017
CDK6 Antagonizes p53-Induced Responses during Tumorigenesis.
Journal: Cancer discovery
Published: August 17, 2017
Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study.
Journal: The Lancet. Haematology
Published: May 01, 2017
Repair of UV-Induced DNA Damage Independent of Nucleotide Excision Repair Is Masked by MUTYH.
Journal: Molecular cell
Published: March 16, 2017
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML.
Journal: Oncotarget
Published: December 14, 2016
Global survey of the immunomodulatory potential of common drugs.
Journal: Nature chemical biology
Published: September 21, 2016
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor.
Journal: Nature chemical biology
Published: November 30, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026